Clinical trials
Lymphoproliferative Disorders trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 3 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 4 |
| Acerta Pharma BV | 1 |
| Amgen Research (Munich) GmbH | 1 |
| Ariad Pharmaceuticals | 1 |
| Pierre Fabre Medicament | 1 |
| Radiation Therapy Oncology Group | 1 |
| Spectrum Pharmaceuticals, Inc | 1 |
| St. Justine's Hospital | 1 |
| Sunnybrook Health Sciences Centre | 1 |
| University Health Network, Toronto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoproliferative Disorders | 14 |
| Lymphoma | 7 |
| Lymphoma, Non-Hodgkin | 6 |
| Neoplasms | 6 |
| Lymphatic Diseases | 5 |
| Immunoproliferative Disorders | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, T-Cell, Cutaneous | 4 |
| Burkitt Lymphoma | 3 |
| Immune System Diseases | 3 |
Trials
Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.